Dr. Patel on Sequencing Therapy in Rectal Cancer

Video

In Partnership With:

Timil Patel, MD, discusses an optimal sequencing strategy in rectal cancer.

Timil Patel, MD, clinical fellow in Hematology/Oncology, Yale School of Medicine, discusses an optimal sequencing strategy in rectal cancer.

Following chemotherapy, patients are restaged, and a multidisciplinary tumor board recommends next steps based on the patient’s response to systemic chemotherapy, says Patel.

Generally, chemoradiation is recommended for patients with a single site of disease who responded well to chemotherapy. Subsequently, a tumor board will decide whether radiation or surgical resection is the optimal approach to treat lung nodules, concludes Patel.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD